BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lodi G, Franchini R, Warnakulasuriya S, Varoni EM, Sardella A, Kerr AR, Carrassi A, MacDonald LC, Worthington HV. Interventions for treating oral leukoplakia to prevent oral cancer. Cochrane Database Syst Rev 2016;7:CD001829. [PMID: 27471845 DOI: 10.1002/14651858.CD001829.pub4] [Cited by in Crossref: 27] [Cited by in F6Publishing: 47] [Article Influence: 4.5] [Reference Citation Analysis]
Number Citing Articles
1 Takashima H, Tagami T, Kato S, Pae H, Ozeki T, Shibuya Y. Three-Dimensional Printing of an Apigenin-Loaded Mucoadhesive Film for Tailored Therapy to Oral Leukoplakia and the Chemopreventive Effect on a Rat Model of Oral Carcinogenesis. Pharmaceutics 2022;14:1575. [DOI: 10.3390/pharmaceutics14081575] [Reference Citation Analysis]
2 Liu H, Tan L, Fu G, Chen L, Tan H. Efficacy of Topical Intervention for Recurrent Aphthous Stomatitis: A Network Meta-Analysis. Medicina 2022;58:771. [DOI: 10.3390/medicina58060771] [Reference Citation Analysis]
3 Ou J, Gao Y, Li H, Ling T, Xie X. Application of 5-aminolevulinic acid-mediated Waterlase-assisted photodynamic therapy in the treatment of oral leukoplakia. Sci Rep 2022;12:9391. [PMID: 35672359 DOI: 10.1038/s41598-022-13497-3] [Reference Citation Analysis]
4 Hou F, Yu Z, Cheng Y, Liu Y, Liang S, Zhang F. Deciphering the Pharmacological Mechanisms of Scutellaria baicalensis Georgi on Oral Leukoplakia By Combining Network Pharmacology, Molecular Docking and Experimental Evaluations. Phytomedicine 2022. [DOI: 10.1016/j.phymed.2022.154195] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Jäwert F, Fehr A, Öhman J, Stenman G, Kjeller G. Recurrent copy number alterations involving EGFR, CDKN2A, and CCND1 in oral premalignant lesions. J Oral Pathol Med 2022. [PMID: 35488777 DOI: 10.1111/jop.13303] [Reference Citation Analysis]
6 Bouaoud J, Bossi P, Elkabets M, Schmitz S, van Kempen LC, Martinez P, Jagadeeshan S, Breuskin I, Puppels GJ, Hoffmann C, Hunter KD, Simon C, Machiels J, Grégoire V, Bertolus C, Brakenhoff RH, Koljenović S, Saintigny P. Unmet Needs and Perspectives in Oral Cancer Prevention. Cancers 2022;14:1815. [DOI: 10.3390/cancers14071815] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
7 Rangel R, Pickering CR, Sikora AG, Spiotto MT. Genetic Changes Driving Immunosuppressive Microenvironments in Oral Premalignancy. Front Immunol 2022;13:840923. [PMID: 35154165 DOI: 10.3389/fimmu.2022.840923] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
8 Teh MT, Ma H, Liang YY, Solomon MC, Chaurasia A, Patil R, Tekade SA, Mishra D, Qadir F, Yeung JS, Liu X, Kriuar S, Zhao R, Waseem A, Hutchison IL. Molecular Signatures of Tumour and Its Microenvironment for Precise Quantitative Diagnosis of Oral Squamous Cell Carcinoma: An International Multi-Cohort Diagnostic Validation Study. Cancers (Basel) 2022;14:1389. [PMID: 35326543 DOI: 10.3390/cancers14061389] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
9 Starska-Kowarska K. Dietary Carotenoids in Head and Neck Cancer-Molecular and Clinical Implications. Nutrients 2022;14:531. [PMID: 35276890 DOI: 10.3390/nu14030531] [Reference Citation Analysis]
10 Walsh T, Warnakulasuriya S, Lingen MW, Kerr AR, Ogden GR, Glenny AM, Macey R. Clinical assessment for the detection of oral cavity cancer and potentially malignant disorders in apparently healthy adults. Cochrane Database Syst Rev 2021;12:CD010173. [PMID: 34891214 DOI: 10.1002/14651858.CD010173.pub3] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
11 Sundberg J, Pandey S, Giglio D, Holmberg E, Kjeller G, Kovács A, Sand LP, Tokozlu B, Öhman J, Sapkota D, Hasséus B. Expression of p53, p63, podoplanin and Ki-67 in recurring versus non-recurring oral leukoplakia. Sci Rep 2021;11:20781. [PMID: 34675318 DOI: 10.1038/s41598-021-99326-5] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
12 Radhakrishnan R, Crane HL, Daigneault M, Padam KSR, Hunter KD. RARβ Expression in Keratinocytes from Potentially Malignant Oral Lesions: The Functional Consequences of Re-Expression by De-Methylating Agents. Cancers (Basel) 2021;13:4064. [PMID: 34439217 DOI: 10.3390/cancers13164064] [Reference Citation Analysis]
13 McCarthy C, Fedele S, Ottensmeier C, Shaw RJ. Early-Phase Interventional Trials in Oral Cancer Prevention. Cancers (Basel) 2021;13:3845. [PMID: 34359746 DOI: 10.3390/cancers13153845] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
14 Archibald H, Buryska S, Ondrey FG. An active surveillance program in oral preneoplasia and translational oncology benefit. Laryngoscope Investig Otolaryngol 2021;6:764-72. [PMID: 34401501 DOI: 10.1002/lio2.612] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
15 Walsh T, Macey R, Kerr AR, Lingen MW, Ogden GR, Warnakulasuriya S. Diagnostic tests for oral cancer and potentially malignant disorders in patients presenting with clinically evident lesions. Cochrane Database Syst Rev 2021;7:CD010276. [PMID: 34282854 DOI: 10.1002/14651858.CD010276.pub3] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
16 McCarthy C, Sacco J, Fedele S, Ho M, Porter S, Liloglou T, Greenhalf B, Robinson M, Young B, Cicconi S, Chauhan S, Tesfaye B, Jackson R, Sherratt F, Shaw R. SAVER: sodium valproate for the epigenetic reprogramming of high-risk oral epithelial dysplasia-a phase II randomised control trial study protocol. Trials 2021;22:428. [PMID: 34225765 DOI: 10.1186/s13063-021-05373-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
17 Bouaoud J, Foy JP, Tortereau A, Michon L, Lavergne V, Gadot N, Boyault S, Valantin J, De Souza G, Zrounba P, Bertolus C, Bendriss-Vermare N, Saintigny P. Early changes in the immune microenvironment of oral potentially malignant disorders reveal an unexpected association of M2 macrophages with oral cancer free survival. Oncoimmunology 2021;10:1944554. [PMID: 34239777 DOI: 10.1080/2162402X.2021.1944554] [Reference Citation Analysis]
18 Sato A, da Fonseca IIM, Nagamine MK, de Toledo GF, Olio R, Hernandez-Blazquez FJ, Yano T, Yeh ES, Dagli MLZ. Effects of Alpha-Connexin Carboxyl-Terminal Peptide (aCT1) and Bowman-Birk Protease Inhibitor (BBI) on Canine Oral Mucosal Melanoma (OMM) Cells. Front Vet Sci 2021;8:670451. [PMID: 34179163 DOI: 10.3389/fvets.2021.670451] [Reference Citation Analysis]
19 Georgaki M, Avgoustidis D, Theofilou VI, Piperi E, Pettas E, Kalyvas DG, Vlachodimitropoulos D, Perisanidis C, Lazaris AC, Nikitakis NG. Recurrence in Oral Premalignancy: Clinicopathologic and Immunohistochemical Analysis. Diagnostics (Basel) 2021;11:872. [PMID: 34066207 DOI: 10.3390/diagnostics11050872] [Reference Citation Analysis]
20 Cerqueira JM, Pontes FS, Santos-Silva AR, Almeida OP, Costa RF, Fonseca FP, Gomez RS, Neto NC, Miyahara LA, Rodrigues-Fernandes CI, Neto ED, Araújo AL. Malignant transformation of oral leukoplakia: a multicentric retrospective study in Brazilian population. Med Oral Patol Oral Cir Bucal 2021;26:e292-8. [PMID: 33247570 DOI: 10.4317/medoral.24175] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
21 Hosmani J, Mushtaq S, Abullais SS, Almubarak HM, Assiri K, Testarelli L, Mazzoni A, Patil S. Recombinant Human Adenovirus-p53 Therapy for the Treatment of Oral Leukoplakia and Oral Squamous Cell Carcinoma: A Systematic Review. Medicina (Kaunas) 2021;57:438. [PMID: 34062896 DOI: 10.3390/medicina57050438] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
22 Pedroso CM, Schemberger GK, Dziadzio JL, Condolo LC, de Camargo Smolarek P. Small Dysplastic Oral Leucoplakia in a Smoking Woman: a Case Report. J Oral Maxillofac Res 2021;12:e5. [PMID: 33959240 DOI: 10.5037/jomr.2021.12105] [Reference Citation Analysis]
23 Girisa S, Kumar A, Rana V, Parama D, Daimary UD, Warnakulasuriya S, Kumar AP, Kunnumakkara AB. From Simple Mouth Cavities to Complex Oral Mucosal Disorders-Curcuminoids as a Promising Therapeutic Approach. ACS Pharmacol Transl Sci 2021;4:647-65. [PMID: 33860191 DOI: 10.1021/acsptsci.1c00017] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
24 Ries J, Agaimy A, Wehrhan F, Baran C, Bolze S, Danzer E, Frey S, Jantsch J, Möst T, Büttner-Herold M, Wickenhauser C, Kesting M, Weber M. Importance of the PD-1/PD-L1 Axis for Malignant Transformation and Risk Assessment of Oral Leukoplakia. Biomedicines 2021;9:194. [PMID: 33669300 DOI: 10.3390/biomedicines9020194] [Cited by in Crossref: 3] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
25 Grigolato R, Bizzoca ME, Calabrese L, Leuci S, Mignogna MD, Lo Muzio L. Leukoplakia and Immunology: New Chemoprevention Landscapes? Int J Mol Sci 2020;21:E6874. [PMID: 32961682 DOI: 10.3390/ijms21186874] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
26 Carenzo A, Serafini MS, Roca E, Paderno A, Mattavelli D, Romani C, Saintigny P, Koljenović S, Licitra L, De Cecco L, Bossi P. Gene Expression Clustering and Selected Head and Neck Cancer Gene Signatures Highlight Risk Probability Differences in Oral Premalignant Lesions. Cells 2020;9:E1828. [PMID: 32756466 DOI: 10.3390/cells9081828] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
27 Contaldo M, Boccellino M, Zannini G, Romano A, Sciarra A, Sacco A, Settembre G, Coppola M, Di Carlo A, D'Angelo L, Inchingolo F, Feola A, Di Domenico M. Sex Hormones and Inflammation Role in Oral Cancer Progression: A Molecular and Biological Point of View. J Oncol 2020;2020:9587971. [PMID: 32684934 DOI: 10.1155/2020/9587971] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
28 Yang SW, Lee YS, Chang LC, Hwang CC, Chen TA. Clincopathological characteristics and treatment outcomes of oral leukoplakia by carbon dioxide laser excision in the elderly patients. Head Neck 2020;42:1014-23. [PMID: 31930772 DOI: 10.1002/hed.26074] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
29 Wils LJ, Poell JB, Evren I, Koopman MS, Brouns EREA, de Visscher JGAM, Brakenhoff RH, Bloemena E. Incorporation of differentiated dysplasia improves prediction of oral leukoplakia at increased risk of malignant progression. Mod Pathol 2020;33:1033-40. [PMID: 31896811 DOI: 10.1038/s41379-019-0444-0] [Cited by in Crossref: 12] [Cited by in F6Publishing: 20] [Article Influence: 6.0] [Reference Citation Analysis]
30 Ma L, Gao X, Liu W. Bibliometric analysis of the top-100 cited articles on oral potentially malignant disorders to guide research topic and direction. J Dent Sci 2020;15:479-85. [PMID: 33505620 DOI: 10.1016/j.jds.2019.09.011] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
31 Sundberg J, Korytowska M, Holmberg E, Bratel J, Wallström M, Kjellström E, Blomgren J, Kovács A, Öhman J, Sand L, Hirsch JM, Giglio D, Kjeller G, Hasséus B. Recurrence rates after surgical removal of oral leukoplakia-A prospective longitudinal multi-centre study. PLoS One 2019;14:e0225682. [PMID: 31810078 DOI: 10.1371/journal.pone.0225682] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 4.3] [Reference Citation Analysis]
32 Irimie AI, Braicu C, Pasca S, Magdo L, Gulei D, Cojocneanu R, Ciocan C, Olariu A, Coza O, Berindan-Neagoe I. Role of Key Micronutrients from Nutrigenetic and Nutrigenomic Perspectives in Cancer Prevention. Medicina (Kaunas) 2019;55:E283. [PMID: 31216637 DOI: 10.3390/medicina55060283] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
33 Salehi B, Lopez-Jornet P, Pons-Fuster López E, Calina D, Sharifi-Rad M, Ramírez-Alarcón K, Forman K, Fernández M, Martorell M, Setzer WN, Martins N, Rodrigues CF, Sharifi-Rad J. Plant-Derived Bioactives in Oral Mucosal Lesions: A Key Emphasis to Curcumin, Lycopene, Chamomile, Aloe vera, Green Tea and Coffee Properties. Biomolecules 2019;9:E106. [PMID: 30884918 DOI: 10.3390/biom9030106] [Cited by in Crossref: 32] [Cited by in F6Publishing: 47] [Article Influence: 10.7] [Reference Citation Analysis]
34 Han Y, Xu S, Jin J, Wang X, Liu X, Hua H, Wang X, Liu H. Primary Clinical Evaluation of Photodynamic Therapy With Oral Leukoplakia in Chinese Patients. Front Physiol 2018;9:1911. [PMID: 30723421 DOI: 10.3389/fphys.2018.01911] [Cited by in Crossref: 7] [Cited by in F6Publishing: 11] [Article Influence: 2.3] [Reference Citation Analysis]
35 van der Waal I. Oral Leukoplakia: Present Views on Diagnosis, Management, Communication with Patients, and Research. Curr Oral Health Rep 2019;6:9-13. [DOI: 10.1007/s40496-019-0204-8] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 1.7] [Reference Citation Analysis]
36 Toti E, Chen CO, Palmery M, Villaño Valencia D, Peluso I. Non-Provitamin A and Provitamin A Carotenoids as Immunomodulators: Recommended Dietary Allowance, Therapeutic Index, or Personalized Nutrition? Oxid Med Cell Longev 2018;2018:4637861. [PMID: 29861829 DOI: 10.1155/2018/4637861] [Cited by in Crossref: 49] [Cited by in F6Publishing: 39] [Article Influence: 12.3] [Reference Citation Analysis]
37 Cloitre A, Rosa RW, Arrive E, Fricain JC. Outcome of CO2 laser vaporization for oral potentially malignant disorders treatment. Med Oral Patol Oral Cir Bucal 2018;23:e237-47. [PMID: 29476671 DOI: 10.4317/medoral.21984] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
38 Carrard VC, van der Waal I. A clinical diagnosis of oral leukoplakia; A guide for dentists. Med Oral Patol Oral Cir Bucal 2018;23:e59-64. [PMID: 29274164 DOI: 10.4317/medoral.22292] [Cited by in Crossref: 3] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
39 Rao UKM, Thavarajah R, Joshua E, Ranganathan K. Loss of heterozygosity as a marker to predict progression of oral epithelial dysplasia to oral squamous cell carcinoma. J Oral Maxillofac Pathol 2018;22:155-60. [PMID: 30158764 DOI: 10.4103/jomfp.JOMFP_151_18] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
40 Staines K, Rogers H. Oral leukoplakia and proliferative verrucous leukoplakia: a review for dental practitioners. Br Dent J 2017;223:655-61. [PMID: 29097794 DOI: 10.1038/sj.bdj.2017.881] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
41 Natekar M, Raghuveer HP, Rayapati DK, Shobha ES, Prashanth NT, Rangan V, Panicker AG. A comparative evaluation: Oral leukoplakia surgical management using diode laser, CO2 laser, and cryosurgery. J Clin Exp Dent 2017;9:e779-84. [PMID: 28638555 DOI: 10.4317/jced.53602] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
42 Pan H, Gu L, Liu B, Li Y, Wang Y, Bai X, Li L, Wang B, Peng Q, Yao Z, Tang Z. Tropomyosin-1 acts as a potential tumor suppressor in human oral squamous cell carcinoma. PLoS One 2017;12:e0168900. [PMID: 28182650 DOI: 10.1371/journal.pone.0168900] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]